A clinical trial to compare the levels of INTERLEUKIN-1BETA ,an inflammatory biomarker around gingiva of orthodontic mini-implant during direct force delivery to mini-implant
Not Applicable
Completed
- Conditions
- Health Condition 1: M264- Malocclusion, unspecified
- Registration Number
- CTRI/2019/04/018439
- Lead Sponsor
- Dr V Sarath kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
a.age group-15-25 years irrespective of gender
b.subject requiring bilateral first premolar extraction
c.patient should be in healthy systemic condition
d.no use of anti-inflammatory drugs in the 6 months preceding the beginning of study
e.healthy periodontal tissue with generalized probing depth less than 3mm
f.willing informed consent/assent
Exclusion Criteria
Not willing to give informed consent.
Ho anti-inflammatory drug administration in 6 months preceding the study.
Non compliant patient with inability to maintain oral hygiene.
Patient with systemic conditions affecting bone metabolism and implant placement.
Patient with history of prior orthodontic treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method levels of IL-1 BETA levels around orthodontic mini-implantsTimepoint: levels of IL-1 BETA levels around orthodontic mini-implants will be assessed during October -November 2020
- Secondary Outcome Measures
Name Time Method comparision of the levels of IL-1Beta levelsTimepoint: 4months